BioWorld

Jan. 17, 2012

View Archived Issues

Record Year for Royalty Deals Builds Optimism for 2012

Not everyone is upset about the turmoil in the equity markets. Last year was a record year for the sale of royalty streams and other structured product deals, in large part because of the lack of other options for biotechs. Read More

Too Many Trials Still Published At a Glacial Pace, or Not at All

Supposedly, academia's battle cry is "publish or perish." So why are so many clinical trials going unpublished? Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Biotech Restructurings, Expansions, Scale-Backs, Bankruptcies: Jan. 1 - Dec. 31, 2011

Read More

Biotech Lawsuits: Jan. 1 - Dec. 31, 2011

Read More

Money Raised By Biotech In 2012 Vs. 2011

Read More

Money Raised By Biotech: Jan. 1 - 13, 2012

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More